Expression of the CTLA-4 Ligand CD86 on Plasmacytoid Dendritic Cells (pDC) Predicts Risk of Disease Recurrence After Treatment Discontinuation in CML

Leukemia - United Kingdom
doi 10.1038/leu.2017.348

Related search